Abstract
Purpose
To establish the optimal and minimally invasive diagnostic approach for targeted next-generation sequencing (NGS) in the indeterminate thyroid tumors.
Methods
The patients with indeterminate thyroid tumors were prospectively recruited and analyzed in a single tertiary medical center. We performed FNA and core needle biopsy (CNB) at the surgical specimens to confirm the quality of each sampling procedure. Cytological diagnosis by FNA, histological diagnosis by CNB and confirmed diagnosis by final surgery were compared to demonstrate the agreement among these approaches for the indeterminate thyroid tumors. The quality of the samples from FNA and CNB was evaluated, respectively to determine the optimal approach for targeted NGS. Finally, we performed ultrasound-guided CNB and FNA (US-CNB and US-FNA) on one case to confirm the clinical feasibility of being a pre-operative minimally invasive diagnostic approach.
Results
A total of 6 female patients (average age: 50.83 ± 15.18 years) with indeterminate thyroid tumors (average size: 1.79 ± 0.91 cm) were recruited for further analyses. The pathological diagnoses could be obtained by CNB in the first five cases, and the sample quality of CNB for targeted NGS was better than that of FNA, even after 10X dilution. The gene mutations associated with thyroid malignancy could be detected by NGS. In the case treated with US-CNB, the pathological and targeted NGS results were successfully obtained, which suggested the possibility of thyroid malignancy to facilitate immediate decision of subsequent treatment.
Conclusion
CNB could serve as a minimally invasive diagnostic approach in the indeterminate thyroid tumors by providing pathological diagnoses and qualified samples for detection of mutated genes, which facilitates appropriate and immediate management.
Similar content being viewed by others
Availability of data and materials
The data that support the findings of this study are not publicly available due to privacy and ethical restrictions, but are available from the corresponding author on reasonable request.
References
Mortensen JD, Woolner LB, Bennett WA (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270–1280
Brito JP, Gionfriddo MR, Al Nofal A et al (2014) The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab 99:1253–1263
Haugen BRM, Alexander EK, Bible KC et al (2015) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. https://doi.org/10.1089/thy.2015.0020
Hoang JK, Lee WK, Lee M, Johnson D, Farrell S (2007) US Features of thyroid malignancy: pearls and pitfalls. Radiographics 27:847–860 (discussion 861-845)
Fish SA, Langer JE, Mandel SJ (2008) Sonographic imaging of thyroid nodules and cervical lymph nodes. Endocrinol Metab Clin N Am 37(401–417):ix
Cibas ES, Ali SZ (2009) The bethesda system for reporting thyroid cytopathology. Thyroid 19:1159–1165
Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW (2012) The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol 56:333–339
Cibas ES, Ali SZ (2017) The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 27:1341–1346
Tee YY, Lowe AJ, Brand CA, Judson RT (2007) Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review. Ann Surg 246:714–720
Wiseman SM, Baliski C, Irvine R et al (2006) Hemithyroidectomy: the optimal initial surgical approach for individuals undergoing surgery for a cytological diagnosis of follicular neoplasm. Ann Surg Oncol 13:425–432
VanderLaan PA, Marqusee E, Krane JF (2011) Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach? Am J Clin Pathol 135:770–775
Beaudenon-Huibregtse S, Alexander EK, Guttler RB et al (2014) Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules. Thyroid 24:1479–1487
Alexander EK, Kennedy GC, Baloch ZW et al (2012) Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 367:705–715
Nikiforov YE, Carty SE, Chiosea SI et al (2014) Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer 120:3627–3634
Nikiforov YE, Ohori NP, Hodak SP et al (2011) Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96:3390–3397
Li H, Robinson KA, Anton B, Saldanha IJ, Ladenson PW (2011) Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab 96:E1719-1726
Pinard R, de Winter A, Sarkis GJ et al (2006) Assessment of whole genome amplification-induced bias through high-throughput, massively parallel whole genome sequencing. BMC Genom 7:216
Hosono S, Faruqi AF, Dean FB et al (2003) Unbiased whole-genome amplification directly from clinical samples. Genome Res 13:954–964
Chen CN, Yang TL (2014) Application of ultrasound-guided core biopsy in head and neck. J Med Ultrasound 22:133–139
Yu SC, Chen CN, Huang HI et al (2014) Diagnosis of Kikuchi-Fujimoto disease: a comparison between open biopsy and minimally invasive ultrasound-guided core biopsy. PLoS ONE 9:e95886
Chen CN, Lin CY, Chi FH et al (2016) Application of ultrasound-guided core biopsy to minimal-invasively diagnose supraclavicular fossa tumors and minimize the requirement of invasive diagnostic surgery. Medicine (Baltimore) 95:e2172
Ho UC, Chen CN, Lin CY et al (2016) Application of ultrasound-guided core biopsy to minimize the non-diagnostic results and the requirement of diagnostic surgery in extrapulmonary tuberculosis of the head and neck. Eur Radiol 26:2999–3005
Chen CN, Huang TC, Yu SC, Ko JY, Yang TL (2022) Incorporation of ultrasound-guided core biopsy with flow cytometry to assist the diagnosis of cervical lymphoma. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-022-07705-z
Carpi A, Sagripanti A, Nicolini A et al (1998) Large needle aspiration biopsy for reducing the rate of inadequate cytology on fine needle aspiration specimens from palpable thyroid nodules. Biomed Pharmacother 52:303–307
Yoon JH, Kim EK, Kwak JY, Moon HJ (2015) Effectiveness and limitations of core needle biopsy in the diagnosis of thyroid nodules: review of current literature. J Pathol Transl Med 49:230–235
Saggiorato E, De Pompa R, Volante M et al (2005) Characterization of thyroid “follicular neoplasms” in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer 12:305–317
Trimboli P, Crescenzi A (2015) Thyroid core needle biopsy: taking stock of the situation. Endocrine 48:779–785
Hong MJ, Na DG, Lee H (2020) Diagnostic efficacy and safety of core needle biopsy as a first-line diagnostic method for thyroid nodules: a prospective cohort study. Thyroid 30:1141–1149
Nasrollah N, Trimboli P, Rossi F et al (2014) Patient’s comfort with and tolerability of thyroid core needle biopsy. Endocrine 45:79–83
Jeong EJ, Chung SR, Baek JH, Choi YJ, Kim JK, Lee JH (2018) A comparison of ultrasound-guided fine needle aspiration versus core needle biopsy for thyroid nodules: pain, tolerability, and complications. Endocrinol Metab (Seoul) 33:114–120
Ha EJ, Suh CH, Baek JH (2018) Complications following ultrasound-guided core needle biopsy of thyroid nodules: a systematic review and meta-analysis. Eur Radiol 28:3848–3860
Ha EJ, Baek JH, Lee JH et al (2017) Complications following US-guided core-needle biopsy for thyroid lesions: a retrospective study of 6,169 consecutive patients with 6,687 thyroid nodules. Eur Radiol 27:1186–1194
Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133
Paja M, del Cura JL, Zabala R et al (2016) Ultrasound-guided core-needle biopsy in thyroid nodules. A study of 676 consecutive cases with surgical correlation. Eur Radiol 26:1–8
Chen CN, Hsieh MS, Lee YH, Yang TL (2022) The efficacy of incorporating ultrasound-guided core biopsy into the clinical workflow of indeterminate thyroid tumors. J Formos Med Assoc 121:2012–2019
Nikiforov YE, Carty SE, Chiosea SI et al (2015) Impact of the multi-gene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology. Thyroid 25:1217–1223
Nikiforova MN, Wald AI, Roy S, Durso MB, Nikiforov YE (2013) Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab 98:E1852-1860
Tuttle RM, Haddad RI, Ball DW et al (2014) Thyroid carcinoma, version 2.2014. J Natl Compr Canc Netw 12:1671–1680 (quiz 1680)
Ho AS, Sarti EE, Jain KS et al (2014) Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 24:832–839
Nikiforov YE, Yip L, Nikiforova MN (2013) New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers. Clin Cancer Res 19:2283–2288
Barollo S, Pennelli G, Vianello F et al (2010) BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability. Eur J Endocrinol 163:659–663
Ricarte-Filho JC, Ryder M, Chitale DA et al (2009) Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res 69:4885–4893
Khurana KK, Xu W, Wang D, Swarnkar A (2015) Rapid on-site evaluation with dynamic telecytopathology for ultrasound-guided fine-needle aspiration of head and neck nonthyroid lesions. J Pathol Inform 6:19
Novoa E, Gurtler N, Arnoux A, Kraft M (2012) Role of ultrasound-guided core-needle biopsy in the assessment of head and neck lesions: a meta-analysis and systematic review of the literature. Head Neck 34:1497–1503
Kim YH, Kwon HJ, Kim EK, Kwak JY, Moon HJ, Yoon JH (2015) Applying ultrasound-guided core needle biopsy for diagnosis of thyroid masses: preliminary results from a single institution. J Ultrasound Med 34:1801–1808
Nikiforov YE (2008) Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 21(Suppl 2):S37-43
Xing M (2013) Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 13:184–199
Xing M, Westra WH, Tufano RP et al (2005) BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90:6373–6379
Hou P, Liu D, Shan Y et al (2007) Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res 13:1161–1170
Wang Y, Hou P, Yu H et al (2007) High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors. J Clin Endocrinol Metab 92:2387–2390
Matsuo Y, Yamashita K, Yoshida T, Satoh Y (2021) Method for preservation of DNA stability of liquid-based cytology specimens from a lung adenocarcinoma cell line. Virchows Arch 478:507–516
Tanaka R, Fujiwara M, Nakazato Y et al (2022) Optimal preservations of cytological materials using liquid-based cytology fixatives for next-generation sequencing analysis. Acta Cytol 66:457–465
Duan H, Liu X, Ren X, Zhang H, Wu H, Liang Z (2019) Mutation profiles of follicular thyroid tumors by targeted sequencing. Diagn Pathol 14:39
Ma LX, Espin-Garcia O, Bedard PL et al (2022) Clinical application of next-generation sequencing in advanced thyroid cancers. Thyroid 32:657–666
Nikitski AV, Nikiforova MN, Yip L, Karslioglu-French E, Carty SE, Nikiforov YE (2021) Can TP53-mutant follicular adenoma be a precursor of anaplastic thyroid carcinoma? Endocr Relat Cancer 28:621–630
Acknowledgements
The authors thank the National Science and Technology Council, the National Taiwan University Hospital, and the staff of the Eighth Core Lab, Department of Medical Research, the National Taiwan University for their support.
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by C-N Chen and T-L Yang. The first draft of the manuscript was written by C-N Chen and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
This study was approved by the Research Ethics Committee A in a tertiary medical center (201512203RINA). Written consent had been obtained from each patient after full explanation of the purpose and nature of all procedures used.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file1 (MP4 4960 KB)
Supplementary file2 (MP4 4604 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, CN., Yang, TL. Histology-based and cytology-based needle sampling for targeted next-generation sequencing in the indeterminate thyroid tumors. Eur Arch Otorhinolaryngol 280, 3773–3781 (2023). https://doi.org/10.1007/s00405-023-07947-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-07947-5